IOL-capsular Complex After Different Intraocular Lenses Implantation in Patients With High Myopia
Launched by WENZHOU MEDICAL UNIVERSITY · Feb 21, 2022
Trial Information
Current as of May 03, 2025
Unknown status
Keywords
ClinConnect Summary
The IOL-capsular complex is formed after cataract surgery and intraocular lens (IOL) implantation. Early postoperative mechanical wrapping of the anterior and posterior capsules plays a significant role in preventing IOL decentration and tilt, as well as formation of the IOL-capsular complex which reduces the incidence of posterior cataract opacity. Although up to 2-3 degree tilt and a 0.2-0.3 mm decentration are common and clinically unnoticed for any design of IOL, larger extent of tilt and decentration has a negative impact on the optical performance. IOL decentration ≥ 0.4 mm or/and IOL...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patients are diagnosed age related cataract or complicated cataract with axial length over 26mm
- • The patients' age over 18 years old
- • The patients plan to receive cataract surgery in Eye hospital of Wenzhou Medical University
- • The dialated pupils are over 6mm
- • Patients are willing and able to complete the follow-ups
- Exclusion Criteria:
- • Patients with other types of cataract
- • Patients have complications in the surgery and after surgery
- • Patients have other severe diseases of eyes
About Wenzhou Medical University
Wenzhou Medical University is a prestigious academic institution in China, dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on medical education, the university fosters collaboration between researchers and healthcare professionals to address pressing medical challenges. Its commitment to excellence in clinical research is reflected in its rigorous methodologies and adherence to ethical standards, ensuring the safety and well-being of trial participants. By leveraging cutting-edge technology and a diverse pool of expertise, Wenzhou Medical University aims to contribute significantly to the global medical community and improve patient outcomes through evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Trial Officials
Yune Zhao
Study Director
Ophthalmology and Optometry Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials